Format

Send to

Choose Destination
Expert Rev Anti Infect Ther. 2014 Jun;12(6):687-96. doi: 10.1586/14787210.2014.892414. Epub 2014 Mar 6.

Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen?

Author information

1
Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Service, 1 Modderfontein Road, Sandringham 2131, Johannesburg, South Africa.

Abstract

Chancroid, caused by Haemophilus ducreyi, has declined in importance as a sexually transmitted pathogen in most countries where it was previously endemic. The global prevalence of chancroid is unknown as most countries lack the required laboratory diagnostic capacity and surveillance systems to determine this. H. ducreyi has recently emerged as a cause of chronic skin ulceration in some South Pacific islands. Although no antimicrobial susceptibility data for H. ducreyi have been published for two decades, it is still assumed that the infection will respond successfully to treatment with recommended cephalosporin, macrolide or fluoroquinolone-based regimens. HIV-1-infected patients require careful follow-up due to reports of treatment failure with single dose regimens. Buboes may need additional treatment with either aspiration or excision and drainage.

KEYWORDS:

HIV-1; Haemophilus ducreyi; azithromycin; ceftriaxone; chancroid; ciprofloxacin; erythromycin; genital ulcer

PMID:
24597521
DOI:
10.1586/14787210.2014.892414
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center